AI-Supported Double Mammogram Reading Improves Detection Rate
By Elana Gotkine HealthDay Reporter
TUESDAY, Jan. 14, 2025 -- Artificial intelligence (AI)-supported double-reading mammography is associated with a higher breast cancer detection rate, without affecting the recall rate, compared with standard double reading, according to a study published online Jan. 7 in Nature Medicine.
Nora Eisemann, Ph.D., from the Institute for Social Medicine and Epidemiology at the University of Lübeck in Germany, and colleagues compared the performance of AI-supported double reading to standard reading (without AI) among women aged 50 to 69 years undergoing organized mammography screening at 12 sites in Germany. Radiologists voluntarily chose whether to use the AI system or not. A total of 463,094 women were screened (260,739 with AI support) by 119 radiologists from July 2021 to February 2023.
The researchers found that the breast cancer detection rate for radiologists in the AI-supported screening group was 6.7 per 1,000, which was 17.6 percent higher than the rate of 5.7 per 1,000 achieved in the control group. In the AI group, the recall rate was 37.4 per 1,000, which was lower than and noninferior to that seen in the control group (38.3 per 1,000). The positive predictive value of recall was 17.9 and 14.9 percent in the AI and control groups, respectively; the positive predictive value of biopsy was 64.5 and 59.2 percent, respectively.
"Our findings substantially add to the growing body of evidence suggesting that AI-supported mammography screening is feasible and safe and can reduce workload," the authors write.
Several authors disclosed ties to medical technology companies, including Vara, which funded the study.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
Broader Formulary Coverage Linked to Lower Odds of MS Relapse
FRIDAY, Aug. 8, 2025 -- Broader formulary coverage is associated with lower odds of multiple sclerosis (MS) relapse among Medicare beneficiaries, according to a study published...
'Heart Age' Often Older Than Chronological Age
FRIDAY, Aug. 8, 2025 -- The Predicting Risk of Cardiovascular Disease Events (PREVENT) equation risk age is older than chronological age on average, with greater discordance for...
Nonlinear Inverse Association Seen for Step Count, Peak Cadence With MACE
THURSDAY, Aug. 7, 2025 -- There are nonlinear, inverse associations for step count and peak cadence with the risk for major adverse cardiovascular events (MACE) among individuals...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.